ARTICLE | Company News
Tyg and Cancer Research UK (CRUK) partnered to develop Tyg’s TYG100. CRUK will conduct a Phase I trial of TYG100 to treat solid tumors. Upon completion of the trial, Tyg will have the option to retain...
BCIQ Target Profiles
Tyg and Cancer Research UK (CRUK) partnered to develop Tyg’s TYG100. CRUK will conduct a Phase I trial of TYG100 to treat solid tumors. Upon completion of the trial, Tyg will have the option to retain...
BCIQ Target Profiles